CKD Bio Corp (063160) Company Profile - CorporateInformation.com


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

CKD Bio Corp Company Snapshot

Business Description:

CKD Bio Corp operates in the Medicinals and botanicals sector. CKD Bio Corp. is a Korea-based company specialized in the manufacturing of pharmaceutical products. The Company mainly provides antibiotic ingredients, consisting of potassium clavulanates, demethylchlortetracyclines (DMCTs) and rifampicins. It also develops immunosuppressive agents including cyclosporin and tacrolimus, and remedies for diabetes such as acarbose. The Company distributes the products in the domestic markets and to the overseas areas such as China, the United States, Europe, Southeast Asia, Africa, Central and South America and the Middle East. In our complete report available for purchase the company is compared to: Kukje Pharmaceutical Industrial Company Limited, Yungjin Pharmaceutical Company Limited and Samil Pharmaceutical Co., Ltd..

CKD Bio Corp

Stock Data:

Recent Stock Performance:

Current Price (2/10/2012): 14,550
(Figures in Korean Won)

1 Week	-2.3%	13 Weeks	-8.8%

4 Weeks	0.3%	52 Weeks	-0.3%

CKD Bio Corp Key Data:

Ticker:	063160	Country:	KOREA (SOUTH)

Exchanges:	SEO	Major Industry:	Drugs, Cosmetics & Health Care

		Sub Industry:	Ethical Drug Manufacturers

2010 Sales	121,568,352,000 (Year Ending Jan 2011).	Employees:	248

Currency:	Korean Won	Market Cap:	74,634,021,300

Fiscal Yr Ends:	December	Shares Outstanding:	5,129,486

Share Type:	Common	Closely Held Shares:	1,499,291

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.